Infertility is a widespread problem, and it is the inability to conceive after having regular unprotected sex. In one-third of the cases, infertility is because of either female infertility factors or male infertility factors. In rest of the cases, the cause is either unknown or a combination of both male and female factors. In males, infertility is due to a couple of factors including low sperm production, abnormal sperm function, or blockages that prevent the delivery of sperm. The cause of infertility can be difficult to diagnose, but many treatments are available. Treatment options depend on underlying problems.
Analysts forecast the Global Infertility market to grow at a CAGR of 4.52 percent over the period 2014-2019.
This report covers the present scenario and the growth prospects of the Global Infertility market for the period 2015-2019. The Global Infertility market can be divided into two segments: Infertility Drugs and Infertility Devices. To calculate the market size, the report considers revenue generated from the sales of various drugs and devices used in the treatment of infertility.
Global Infertility Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Infertility market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
- Bayer Healthcare
- Ferring Pharmaceuticals
- Merck & Co.
Other Prominent Vendors
- Abbott Laboratories
- Apricus Biosciences
- Bristol-Myers Squibb
- Dong-A Socio
- Elelixis Diagnostics
- Eli Lily
- Halotech DNA
- HRA Pharma
- Invo Bioscience
- Medical Electronic Systems
- Increase in Aging Population
- Patent Expires of Major Blockbuster Drugs
- Increase in Awareness
Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Have any Query on the Report get your Queries Resolved at http://www.sandlerresearch.org/inquire-before-buying?rname=31298 .
(Prices start at US $2500 for a single user PDF)
Healthcare IT refers to the use of IT services, products, software, and solutions by healthcare organizations to integrate and streamline various processes. In healthcare, IT is used to develop a secure environment and maintain a uniform flow of information. It improves the quality and efficiency of the services delivered and helps in reducing errors in the Healthcare industry. The rising number of healthcare institutions and the emerging need to modernize the same is contributing to the growth of healthcare IT.
Healthcare IT refers to the use of IT services, products, software, and solutions by healthcare organizations to integrate and streamline various processes. In healthcare, IT is primarily used to develop a secure environment and maintain a uniform flow of information. It improves the quality and efficiency of the services delivered and helps in reducing errors in the Healthcare industry. The rising number of healthcare institutions and the emerging need to modernize the same is proliferating the growth of healthcare IT.